Take our poll: Have you received advice from your healthcare provider about monitoring your heart health?
Share with us: Heart issue(s) and breast cancer: What's your story?
Trodelvy Improves Progression-Free Survival for HR+, HER2- MBC
moderators
Posts: 8,956
Trodelvy Slightly Improves Progression-Free Survival for Pre-treated Metastatic Hormone Receptor-Positive, HER2-Negative Breast Cancer
June 8, 2022
Trodelvy (chemical name: sacituzumab govitecan-hziy) slightly improved progression-free survival in people diagnosed with metastatic hormone receptor-positive, HER2-negative breast cancer previously treated with hormonal therapy, a CDK4/6 inhibitor, and multiple lines of chemotherapy. Read more...
0
Categories
Join Us on Zoom: Upcoming virtual support groups. Read more...